<DOC>
	<DOCNO>NCT00260741</DOCNO>
	<brief_summary>The purpose study learn use inhale cannabis ( marijuana ) oral cannabinoid ( dronabinol , Marinol THC , active ingredient marijuana ) safe effective reducing symptom spasticity tremor patient secondary-progressive primary progressive multiple sclerosis .</brief_summary>
	<brief_title>Cannabis Spasticity Multiple Sclerosis</brief_title>
	<detailed_description>The treatment MS far satisfactory . For acute attack , high dose corticosteroid seem reduce duration attack reduce likelihood future attack . Immunomodulatory agent , available disease last decade , reduce frequency severe attack one third . The remainder treatment symptomatic , aim reduce disability already present . Recent research CB1 CB2 cannabinoid receptor system suggest cannabis may potential affect pathogenic mechanism symptom MS . In light autoimmune hypothesis etiology MS , THC could directly alter immune function manner might reduce ( increase ) primary pathology disease . Comparisons : Three treatment arm compare : 1 ) inhale cannabis oral placebo , 2 ) inhale placebo oral THC , 3 ) inhale placebo oral placebo , effect agent analyze thirty sixty day .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<criteria>Diagnosis clinically definite multiple sclerosis define Poser criterion Primary secondary disease course Moderate severe spasticity Age 21 old Preexisting pulmonary condition , include poorly control asthma , chronic bronchitis , emphysema , bronchiectasis , significant pulmonary disorder Preexisting cardiac condition , include ischemic heart disease , congestive heart failure , significant cardiac disorder Inability abstain tobacco marijuana smoking , use alcohol sedative hypnotic medication duration study Past history abuse recreational drug , include marijuana alcohol last 12 month History currently meet DSMIV criterion dependence cannabis Use cannabis , marijuana , THC last two week Preexisting dementia , mania , depression , schizophrenia poorly control psychiatric illness Exacerbation MS within 30 day prior screenin visit Current use cyclophosphamide , mitoxanthrone , cladribine Arthritis , bony soft tissue disorder interfere spasticity measure Inability provide inform consent Recent cannabis use twice per week one month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>cannabis</keyword>
	<keyword>marijuana</keyword>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Spasticity</keyword>
</DOC>